Summary
The prostate is a walnut-sized gland located behind the base of a man's penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.
The global Prostate Cancer Diagnostics market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
Genomic Health
Abbott
OPKO
Siemens Healthcare
DiaSorin
bioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics
Major applications as follows:
< 55
55-75
> 75
Major Type as follows:
Tumor Biomarker Tests
Imaging
Biopsy
Others
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Table of Contents
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Type
1.1.5 Scope of Regions/Countries
1.2 Global Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 Genomic Health
3.1.1 Company Information
3.1.2 Product & Services
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.1.4 Recent Development
3.2 Abbott
3.2.1 Company Information
3.2.2 Product & Services
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2.4 Recent Development
3.3 OPKO
3.3.1 Company Information
3.3.2 Product & Services
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3.4 Recent Development
3.4 Siemens Healthcare
3.4.1 Company Information
3.4.2 Product & Services
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4.4 Recent Development
3.5 DiaSorin
3.5.1 Company Information
3.5.2 Product & Services
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5.4 Recent Development
3.6 bioMeriux
3.6.1 Company Information
3.6.2 Product & Services
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6.4 Recent Development
3.7 Roche
3.7.1 Company Information
3.7.2 Product & Services
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7.4 Recent Development
3.8 MDx Health
3.8.1 Company Information
3.8.2 Product & Services
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8.4 Recent Development
3.9 Beckman Coulter
3.9.1 Company Information
3.9.2 Product & Services
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9.4 Recent Development
3.10 Myriad Genetics
3.10.1 Company Information
3.10.2 Product & Services
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 Ambry Genetics
3.11.1 Company Information
3.11.2 Product & Services
3.11.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
4.1 < 55
4.1.1 Overview
4.1.2 < 55 Market Size and Forecast
4.2 55-75
4.2.1 Overview
4.2.2 55-75 Market Size and Forecast
4.3 > 75
4.3.1 Overview
4.3.2 > 75 Market Size and Forecast
5 Market by Type
5.By Tumor Biomarker Tests
5.1 Tumor Biomarker Tests
5.1.1 Overview
5.1.2 Tumor Biomarker Tests Market Size and Forecast
5.2 Imaging
5.2.1 Overview
5.2.2 Imaging Market Size and Forecast
5.3 Biopsy
5.3.1 Overview
5.3.2 Biopsy Market Size and Forecast
5.4 Others
5.4.1 Overview
5.4.2 Others Market Size and Forecast
6 Price Overview
6.1 Price by Manufacturers
6.2 Price by Application
6.3 Price by Type
7 Conclusion
Fig Global Prostate Cancer Diagnostics Market Size and CAGR 2013-2018 (Million USD)
Fig Global Prostate Cancer Diagnostics Market Size and CAGR 2013-2018 (Volume)
Fig Global Prostate Cancer Diagnostics Market Forecast and CAGR 2019-2025 (Million USD)
Fig Global Prostate Cancer Diagnostics Market Forecast and CAGR 2019-2025 (Volume)
Fig < 55 Market Size and CAGR 2013-2018 (Million USD)
Fig < 55 Market Size and CAGR 2013-2018 (Volume)
Fig < 55 Market Forecast and CAGR 2019-2025 (Million USD)
Fig < 55 Market Forecast and CAGR 2019-2025 (Volume)
Fig 55-75 Market Size and CAGR 2013-2018 (Million USD)
Fig 55-75 Market Size and CAGR 2013-2018 (Volume)
Fig 55-75 Market Forecast and CAGR 2019-2025 (Million USD)
Fig 55-75 Market Forecast and CAGR 2019-2025 (Volume)
Fig > 75 Market Size and CAGR 2013-2018 (Million USD)
Fig > 75 Market Size and CAGR 2013-2018 (Volume)
Fig > 75 Market Forecast and CAGR 2019-2025 (Million USD)
Fig > 75 Market Forecast and CAGR 2019-2025 (Volume)
Fig Tumor Biomarker Tests Market Size and CAGR 2013-2018 (Million USD)
Fig Tumor Biomarker Tests Market Size and CAGR 2013-2018 (Volume)
Fig Tumor Biomarker Tests Market Forecast and CAGR 2019-2025 (Million USD)
Fig Tumor Biomarker Tests Market Forecast and CAGR 2019-2025 (Volume)
Fig Imaging Market Size and CAGR 2013-2018 (Million USD)
Fig Imaging Market Size and CAGR 2013-2018 (Volume)
Fig Imaging Market Forecast and CAGR 2019-2025 (Million USD)
Fig Imaging Market Forecast and CAGR 2019-2025 (Volume)
Fig Biopsy Market Size and CAGR 2013-2018 (Million USD)
Fig Biopsy Market Size and CAGR 2013-2018 (Volume)
Fig Biopsy Market Forecast and CAGR 2019-2025 (Million USD)
Fig Biopsy Market Forecast and CAGR 2019-2025 (Volume)
Fig Others Market Size and CAGR 2013-2018 (Million USD)
Fig Others Market Size and CAGR 2013-2018 (Volume)
Fig Others Market Forecast and CAGR 2019-2025 (Million USD)
Fig Others Market Forecast and CAGR 2019-2025 (Volume)